Glyconanoparticle Storage Stability Study Service
Overview of Glyconanoparticle Storage Stability Study
Glyconanoparticles play a key role as promising biomaterials in drug delivery, vaccine development, and bioimaging applications. The storage stability of glyconanoparticles directly impacts their efficacy in practical use. Therefore, we introduce the glyconanoparticle storage stability study service, which comprehensively evaluates the stability of glyconanoparticles under various storage conditions to ensure optimal performance in practical applications.
At CD BioGlyco, our service is grounded in the advanced GlycoNano™ Platform, which integrates key technologies for the research, preparation, characterization, and stability assessment of glyconanoparticles. Building upon this platform, we have further expanded the Glyconanoparticle Preclinical Study Service, offering comprehensive support for preclinical research on glyconanoparticles. Glyconanoparticle Stability Study Service, specifically, focuses on the stability assessment of glyconanoparticles, with storage stability studies being a top priority.
Unlock the Secrets of Glyconanoparticle Longevity with Our Expert Storage Stability Study
In our glyconanoparticle stability study service, we place particular emphasis on several key stability indicators that are carefully evaluated using advanced techniques:
Temperature Stability
Temperature is a critical factor affecting the stability of glyconanoparticles. At different temperatures, glyconanoparticles may undergo degradation, aggregation, or precipitation, impacting their biological activity and targeting capabilities.
- Techniques: We utilize dynamic light scattering (DLS), electrophoretic light scattering (ELS), and transmission electron microscopy (TEM) to monitor changes in particle size distribution, zeta potential, and morphology of glyconanoparticles at various temperatures, including 4°C, 25°C, and low temperatures.
- Procedure: Glyconanoparticle samples are placed in incubators set to specific temperatures, and regular sampling is conducted for the aforementioned measurements. By comparing data at different time points, the temperature stability of glyconanoparticles is assessed.
- Result Interpretation: Stability in particle size distribution, changes in zeta potential, and morphology integrity are used to comprehensively judge the storage stability of glyconanoparticles at different temperatures.
Radiation Stability
Radiation, especially ultraviolet (UV) radiation, can initiate photochemical reactions in glyconanoparticles and their core components, such as oxidation and degradation, affecting their stability and biological activity.
- Techniques: UV-visible spectrophotometry and fluorescence spectroscopy are employed to monitor changes in absorption and fluorescence spectra of glyconanoparticles under different light intensities.
- Procedure: Glyconanoparticle samples are exposed to various intensities of light, and regular sampling is conducted for spectral analysis. By comparing spectral data under different lighting conditions, the light stability of glyconanoparticles is evaluated.
- Result Interpretation: Stability in spectral data is used to judge the stability of glyconanoparticles under lighting conditions.
Freeze-Thaw Stability
Freeze-thaw cycles can lead to aggregation, degradation, or chemical property changes in glyconanoparticles, impacting their biological activity and targeting capabilities.
- Techniques: DLS, ELS, and TEM are used to monitor changes in particle size distribution, zeta potential, and morphology of glyconanoparticles during freeze-thaw cycles.
- Procedure: Glyconanoparticle samples are subjected to freezing and thawing cycles multiple times, with sampling conducted after each cycle for the aforementioned measurements.
- Result Interpretation: Stability in particle size distribution, changes in zeta potential, and morphology integrity are used to comprehensively judge the stability of glyconanoparticles during freeze-thaw cycles.
Long-Term Storage Stability
Long-term storage can result in aggregation, degradation, or chemical property changes in glyconanoparticles, impacting their efficacy and safety in practical applications.
- Techniques: A variety of techniques, including DLS, ELS, TEM, Fourier transform infrared spectroscopy (FTIR), and nuclear magnetic resonance (NMR), are employed to monitor changes in the properties of glyconanoparticles during long-term storage.
- Procedure: Glyconanoparticle samples are placed under specified storage conditions (e.g., temperature, humidity, lighting), and regular sampling is conducted for the aforementioned measurements. By comparing data at different time points, the long-term storage stability of glyconanoparticles is assessed.
- Result Interpretation: A comprehensive analysis of the testing data is conducted to judge the stability of glyconanoparticles during long-term storage. Customized reports are provided, detailing the test results at each time point and the stability assessment based on these results.
Workflow
Our glyconanoparticle storage stability study service workflow includes project initiation with clients, experiment design tailored to needs, sample preparation, stability testing across various conditions, data analysis, results feedback with tailored suggestions, and final report delivery.

Applications of Glyconanoparticle Storage Stability Study
- Pharmaceutical Industry: Glyconanoparticle storage stability study can be used to test the stability of glyconanoparticles used in drug delivery systems, thereby improving the efficacy and shelf life of their products.
- Biotechnology Research: The storage stability study can be used to help biotechnology researchers understand the stability characteristics of glyconanoparticles under different conditions.
- Nanodrug Development: A study of glyconanoparticle storage stability can be used to gain insight into the long-term stability of glyconanoparticles in potential medical applications.
Advantages
- Comprehensive Analysis: Our service offers a comprehensive analysis of glyconanoparticle stability, covering multiple conditions and parameters to ensure accurate and reliable results.
- Customized Solutions: We tailor our experimental designs to meet the specific needs of each client, providing customized solutions that address their unique research or product development challenges.
- Expert Interpretation: Our team of experts interprets the data and provides clear, actionable insights, helping clients make informed decisions based on the results of their stability studies.
Publication
Technology: Assessment of lipid nanoparticle (LNP) and liposome storage stability
Published: 2023
Journal: Langmuir
IF: 3.7
Results: The study describes the establishment of candidate reference materials for lipid nanoparticles and liposomes and assesses their storage stability. These materials were stored at −70°C, demonstrating stability and homogeneity for at least nine months, with minimal variability observed in particle size. However, variations in storage conditions at 4°C showed different stability impacts, emphasizing the critical role of maintaining proper storage temperatures for preserving nanoparticle integrity.
Fig.1 PdI–Z-avr and Z-avr–time plots illustrating the size and polydispersity evolution of two sets of anionic LNPs stored at 4°C. (Jakubek, et al., 2023)
Our Services
Glyconanoparticle Formulation Service
We offer comprehensive glyconanoparticle formulation services, catering to a wide range of applications including Drug-loaded, Biological Agent-loaded, Diagnostic Agent-loaded, Nutrient-loaded, Cosmetic Ingredient-loaded, and Agricultural Chemical-loaded formulations. These services are pivotal in preparing our clients' glyconanoparticles for subsequent stability studies, seamlessly integrating with our glyconanoparticle storage stability study service to ensure robust product performance.

Frequently Asked Questions
- What is the glyconanoparticle storage stability study service and why is it important to my research project?
The glyconanoparticle storage stability study service is a professional biotechnology service designed to evaluate the physical, chemical, and biological stability of glyconanoparticles under different storage conditions. These nanoparticles have a wide range of applications in biomedicine, vaccine development, tissue engineering, and other fields due to their unique biocompatibility, targeting ability, and drug delivery potential. Through this service, you can understand the stability performance of glyconanoparticles under different conditions such as temperature, light, and storage time, which is crucial to ensure the safety and effectiveness of your products during production, transportation, and use. - Can you provide a solution if my glyconanoparticles are unstable under certain conditions?
Yes, our services are not limited to data collection and analysis. Suppose glyconanoparticles are found to be unstable under certain conditions. In that case, our team of scientists will provide a range of possible solutions based on your specific needs, including but not limited to adjusting the formulation, improving the preparation process, using new stabilizers, optimizing storage conditions, etc. We are committed to working with you to overcome stability challenges and enhance the market competitiveness of your products.
At CD BioGlyco, our glyconanoparticle storage stability study service focuses on scientifically evaluating the stability of glyconanoparticles under various storage conditions to help clients optimize product performance and shelf life. We sincerely invite you to contact us to explore more possibilities and ensure the success of your glyconanoparticle development project.
Reference
- Jakubek, Z. J.; et al. Lipid nanoparticle and liposome reference materials: assessment of size homogeneity and long-term− 70°C and 4°C storage stability. Langmuir. 2023, 39(7): 2509-2519.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




